Menu Search
Equities

MustGrow Biologics Corp

MGRO:CVE

MustGrow Biologics Corp

Actions
  • Price (CAD)1.81
  • Today's Change-0.03 / -1.63%
  • Shares traded11.93k
  • 1 Year change+63.06%
  • Beta1.3808
Data delayed at least 15 minutes, as of Nov 22 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CADView more

In 2023, MustGrow Biologics Corp did not generate a significant amount of cash. Cash Flow from Financing totalled 95.75k or 2.03% of revenues. In addition the company used 294.76k for operations while cash used for investing totalled .
Cash flow per share-0.0083
Price/Cash flow per share--
Book value per share0.0726
Tangible book value per share0.0726
More ▼

Balance sheet in CADView more

MustGrow Biologics Corp appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio4.87
Quick ratio4.84
Total debt/total equity0.1383
Total debt/total capital0.1215
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.